» Articles » PMID: 2168560

Allele Loss on Chromosome 16 Associated with Progression of Human Hepatocellular Carcinoma

Overview
Specialty Science
Date 1990 Sep 1
PMID 2168560
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Loss of heterozygosity on chromosome 16 is a common genetic alteration in human hepatocellular carcinoma (HCC). To clarify the pathogenetic significance of allele loss on chromosome 16, we performed restriction fragment length polymorphism analysis of 70 surgically resected tumors by using 15 polymorphic DNA markers for chromosome 16. Loss of heterozygosity on chromosome 16 was detected in 36 (52%) of 69 informative cases, and the common region of allele loss in these 36 tumors was located between the HP locus (16q22.1) and the CTRB locus (16q22.3-q23.2). These losses occurred more frequently in HCCs of poor differentiation, of larger size, and with metastasis, whereas they were not detected in HCC at the earliest stage. In addition, these losses were not associated with presence or absence of hepatitis B virus DNA integration or hepatitis C virus infection. These results show that loss of heterozygosity on chromosome 16 is a late event occurring after hepatocarcinogenesis and strongly suggest that this phenomenon is involved in enhancement of tumor aggressiveness during progression of HCC.

Citing Articles

Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.

Wang M, Yan X, Dong Y, Li X, Gao B PLoS Comput Biol. 2024; 20(5):e1012113.

PMID: 38728362 PMC: 11230636. DOI: 10.1371/journal.pcbi.1012113.


Molecular pathological approach to cancer epigenomics and its clinical application.

Kanai Y Pathol Int. 2024; 74(4):167-186.

PMID: 38482965 PMC: 11551818. DOI: 10.1111/pin.13418.


Integrated Analysis of Ulcerative Colitis Revealed an Association between and Immune Infiltration.

Li T, Liu W, Hui W, Shi T, Liu H, Feng Y Dis Markers. 2022; 2022:4983471.

PMID: 35308140 PMC: 8931176. DOI: 10.1155/2022/4983471.


PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling.

Baffi T, Cohen-Katsenelson K, Newton A Annu Rev Pharmacol Toxicol. 2020; 61:723-743.

PMID: 32997603 PMC: 11003498. DOI: 10.1146/annurev-pharmtox-031820-122108.


Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma.

Jin H, Zhang Y, You H, Tao X, Wang C, Jin G Sci Rep. 2015; 5:10466.

PMID: 26099564 PMC: 4479133. DOI: 10.1038/srep10466.


References
1.
Buetow K, Murray J, Israel J, London W, Smith M, Kew M . Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1989; 86(22):8852-6. PMC: 298388. DOI: 10.1073/pnas.86.22.8852. View

2.
Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S . Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990; 87(17):6547-9. PMC: 54573. DOI: 10.1073/pnas.87.17.6547. View

3.
Nigro J, Baker S, Preisinger A, Jessup J, Hostetter R, Cleary K . Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989; 342(6250):705-8. DOI: 10.1038/342705a0. View

4.
Fearon E, Cho K, Nigro J, Kern S, Simons J, Ruppert J . Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990; 247(4938):49-56. DOI: 10.1126/science.2294591. View

5.
Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M . Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A. 1990; 87(3):983-7. PMC: 53394. DOI: 10.1073/pnas.87.3.983. View